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Abstract: Spermatogonial stem cell (SSC) transplantation therapy is a promising strategy to renew
spermatogenesis for prepubertal boys whose fertility is compromised. However, propagation of SSCs
is required due to a limited number of SSCs in cryopreserved testicular tissue. This propagation
must be done under xeno-free conditions for clinical application. SSCs were propagated from
infant testicular tissue (7 mg and 10 mg) from two boys under xeno-free conditions using human
platelet lysate and nutrient source. We verified SSC-like cell clusters (SSCLCs) by quantitative
real-time polymerase chain reaction (PCR) and immune-reaction assay using the SSC markers
undifferentiated embryonic cell transcription factor 1 (UTF1), ubiquitin carboxyl-terminal hydrolase
isozyme L1 (UCHL1), GDNF receptor alpha-1 (GFRα-1) Fα and promyelocytic leukaemia zinc finger
protein (PLZF). The functionality of the propagated SSCs was investigated by pre-labelling using
green fluorescent Cell Linker PKH67 and xeno-transplantation of the SSCLCs into busulfan-treated,
therefore sterile, immunodeficient mice. SSC-like cell clusters (SSCLCs) appeared after 2 weeks
in primary passage. The SSCLCs were SSC-like as the UTF1, UCHL1, GFRα1 and PLZF were all
positive. After 2.5 months’ culture period, a total of 13 million cells from one sample were harvested
for xenotransplantation. Labelled human propagated SSCs were identified and verified in mouse
seminiferous tubules at 3–6 weeks, confirming that the transplanted cells contain SSCLCs. The present
xeno-free clinical culture protocol allows propagation of SSCs from infant boys.
Keywords: Spermatogonial stem cells; xeno-free culture; male fertility cryopreservation;
xeno-transplantation; in vitro propagation
1. Introduction
Advances in cancer detection and therapy have greatly improved survival rates for childhood
cancer patients and nowadays the vast majority will become long-term survivors. Approximately 1 in
530 young adults between the ages of 20 and 39 years is a childhood cancer survivor [1]. However,
treatment of childhood cancers can adversely impact on the reproductive function [2]. To restore
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fertility in childhood cancer survivors, options for fertility preservation prior to gonadotoxic cancer
therapies are needed [3]. For adult men, semen cryopreservation has been well-established for many
years. However, cryopreservation of spermatozoa is not an option for prepubertal boys as they have
no spermatogenesis yet [4]. Cryopreservation of immature testicular biopsy (ITT) for storage of
spermatogonial stem cells (SSCs) is a preventive strategy for prepubertal boys facing gonadotoxic
cancer therapy which has been available for more than a decade in different reproductive centres
worldwide [5,6]. Furthermore, a number of non-malignant diseases may cause infertility, where
patients also potentially could benefit from testicular tissue cryopreservation [5]. For instance, about
35% of boys who undergo orchidopexy, might exhibit reduced sperm concentrations, although early
orchiopexy is suggested to limit the risks [7]. Nowadays, about 17% of azoospermia men have a history
of cryptorchidism [8].
Testicular tissue engraftment, SSC auto-transplantation and in vitro spermatogenesis are
considered as the three main approaches to rescue fertility after the boys have reached adulthood [9].
However, all strategies are still experimental. Establishment of a standard clinical procedure for
cryopreserved testicular tissue to rescue fertility is an urgent demand.
SSC transplantation to restore spermatogenesis has been reported in mice first [10,11], and
subsequently demonstrated in other mammalian animals, such as pig, cow, and monkey [12–14]. SSC
auto-transplantation is now being proposed as a strategy to reinitiate spermatogenesis and rescue
male infertility in the clinic [15]. To implement SSC transplantation methods successfully, in vitro
propagation of SSCs is an essential step due to the limited number of SSCs in cryopreserved tissue [16].
In addition, the malignant cells may be eliminated and eventually disappear during the process of SSC
propagation [17].
Currently, there are more than 20 published reports about human SSC culture [18]. Each centre
has a unique protocol to culture human SSCs and used different outcome assessments, therefore,
no consensus is accepted so far to replicate an SSC culturing method. Noticeably, in all studies,
animal-derived products such as bovine serum albumin (BSA) or fetal bovine serum (FBS) were used
in the culture media. Xenogeneic culture carries risks, in particular of transmission of known or as
yet unrecognized xenogeneic infectious agents from animals to human beings and from recipients of
xenogeneic transplants to their contacts and the public at large. Since xeno-free serum replacement has
not been introduced so far, the clinical utilization of the SSCs is not possible. Therefore, establishing a
xeno-free protocol for human SSC culture has utmost importance for clinical translation.
Although an announcement reported the establishment of a xeno-free culture system for expansion
of human SSC, the culture media contained FBS and thereby xenogeneic [19]. In this paper, we present
a xeno-free culture system using clinical-grade human platelet lysate (hPL) for the integration of SSC
propagation into clinical application. The expanded SSCs were verified by xenotransplantation in
sterile nude mice.
2. Results
2.1. Quantification of Germ Cells in Testicular Biopsies
To explore the potential SSC expansion in vitro, two testis samples from boys with bilateral
cryptorchidism were investigated. The germ cell numbers per seminiferous tubule cross-section were
0.035 and 0.444, respectively. The number of type A dark spermatogonia (Ad spermatogonia) per
seminiferous tubule cross-section was 0.004 and 0.01, respectively. The histological appearance and
immunohistochemical analysis are shown in Figure 1.
2.2. Expansion of Spermatogonial Stem Cells (SSCs) In Vitro
To propagate SSCs in vitro, a differential plate method was applied. After overnight incubation,
floating cells considered as SSC enriched were isolated and cultured in StemPro-34 medium completed
with multiple growth factors and hPL (Figure 2b). The attached cells in minimum essential media
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(MEM) media, considered as somatic cells, were confluent after 12 days and no clusters formed
(Figure 2a). After 2 weeks, SSC-like cell clusters formed and developed as the grape-like cell clusters
(Figure 2c). After around 1 month, the cells were passaged. Clusters that consistently formed in
passage one, two and three are shown in Figure 2d–f. After 2.5 months’ culture period, a total of 13
million cells from one sample were harvested for xenotransplantation.Int. J. Mol. Sci. 2019, x, x FOR PEER REVIEW 3 of 15 
 
 
Figure 1. Hematoxylin and eosin (HE) staining and immunohistochemistry by CD99, PLAP and D2-
40 in undescended testis aged 0.8 and 1.1 years old, respectively. HE staining (a,e); CD99 
immunohistochemistry (b,f); PLAP immunohistochemistry (c,g); D2-40 immunohistochemistry (d,h); 
Arrows show the germ cells. CD99: cluster of differentiation 99; PLAP: placental alkaline 
phosphatase, D2-40: podoplanin; Scale bars: 100 µm. 
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Figure 1. Hematoxylin and eosin (HE) staining and immunohistochemistry by CD99, PLAP and
D2-40 in undescended testis aged 0.8 and 1.1 years old, respectively. HE staining (a,e); CD99
immunohistochemistry (b,f); PLAP immunohistochemistry (c,g); D2-40 immunohistochemistry (d,h);
Arrows show t e germ cells. CD99: cluster of differentiation 99; PLAP: placental alkaline phosphatase,
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Figure 2. Spermatogonial stem cell (SSC)-like cell clusters were continuously formed in vitro. (a) The 
attached cell from the first plate formed confluence after 12 days. (b) SSC-enriched fractions (floating 
cell in first plates) was subsequently cultured in the StemPro-34 stem cell xeno-free media. (c–f) SSC-
like cell clusters were formed in primary, first, second and third passages derived from SSC-enriched 
fractions cultured in xeno-free media. Arrows show the SSC-like cell clusters. Scale bars: 200 µm. 
2.3. Molecular Analysis of SSC-Like Cells  
To investigate the molecular properties of SSC-like cells a sectioned SSC-like cell cluster was 
immunohistochemically stained using different SSC markers, including undifferentiated embryonic 
cell transcription factor 1 (UTF1), GDNF family receptor alpha-1 (GFRα-1), ubiquitin carboxyl-
terminal hydrolase isozyme L1 (UCHL1), which are all positively shown in SSC-like cell clusters 
(Figure 3). The antibody specificity was demonstrated by immunohistochemistry on a 0.8 years old 
cryptorchid testis (supplementary Figure S1). The proliferation rate was investigated using Ki67 
antibody. Dual immunostaining with UFT1 and Ki67 is shown in Figure 4, which demonstrated few 
proliferating cells in the clusters. The SSC features of SSC-like cell clusters (SSCLCs) was further 
confirmed via real-time quantitative polymerase chain reaction (PCR) using different probes, 
including SSC markers, UCHL1 and promyelocytic leukaemia zinc finger protein (PLZF) from single 
cell cluster of different passages (Figure 5).  
Figure 2. Spermatogonial stem cell (SSC)-like cell clusters were continuously formed in vitro. (a) The
attached cell from the first plate formed confluence after 12 days. (b) SSC-enriched fractions (floating
cell in first plates) was subsequently cultured in the StemPro-34 stem cell xeno-free media. (c–f) SSC-like
cell clusters were formed in primary, first, second and third passag derived from SSC-enriched
fractions cultured in xeno-free media. Arrows show the SSC-like cell clusters. Scale bars: 200 µm.
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2.3. Molecular Analysis of SSC-Like Cells
To investigate the molecular properties of SSC-like cells a sectioned SSC-like cell cluster was
immunohistochemically stained using different SSC markers, including undifferentiated embryonic
cell transcription factor 1 (UTF1), GDNF family receptor alpha-1 (GFRα-1), ubiquitin carboxyl-terminal
hydrolase isozyme L1 (UCHL1), which are all positively shown in SSC-like cell clusters (Figure 3).
The antibody specificity was demonstrated by immunohistochemistry on a 0.8 years old cryptorchid
testis (supplementary Figure S1). The proliferation rate was investigated using Ki67 antibody. Dual
immunostaining with UFT1 and Ki67 is shown in Figure 4, which demonstrated few proliferating cells
in the clusters. The SSC features of SSC-like cell clusters (SSCLCs) was further confirmed via real-time
quantitative polymerase chain reaction (PCR) using different probes, including SSC markers, UCHL1
and promyelocytic leukaemia zinc finger protein (PLZF) from single cell cluster of different passages
(Figure 5).
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negative control. Scale bars: 50 µm. 
 
 
Figure 4. SSC-like cell clusters contain a few proliferating cells. Double immunofluorescence staining 
of SSC-like cell clusters (a) undifferentiated embryonic cell transcription factor 1 (UTF1); (b) antigen 
KI-67 (Ki67); (c): nuclear staining with 4′,6-diamidino-2-phenylindole (DAPI); (d) merged from three 
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Figure 3. SSC-like cell clusters express SSC markers. Immunostaining f cross sections of SSC-like cell
clusters by (a) undifferentiated embryonic cell transcription factor 1 (UTF1), (b) GDNF family receptor
alpha-1 (GFRα-1), (c) ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1), and (d) IgG negative
control. Scale bars: 50 µm.
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Figure 4. SSC-like cell clusters contain a few proliferating cells. Double immunofluorescence staining
of SSC-like cell clusters (a) undifferentiated embryonic cell transcription factor 1 (UTF1); (b) antigen
KI-67 (Ki67); (c): nu lear aining with 4′,6-dia idino-2-phe yl ndole (DAPI); (d) merged from three
channels. Arrows sho ing the proliferating cells in the surface layer of clusters. Scale bars: 50 µm.
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Figure 5. SSC-like cell clusters transcribe the message RNA of SSC markers during passaging. (a) Real-
time quantification of the expression level of the SSC markers, ubiquitin carboxyl-terminal hydrolase 
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Figure 5. SSC-like cell clusters transcribe the message RNA of SSC markers during passaging.
(a) Real-time quantification of the expression level of the SSC markers, ubiquitin carboxyl-terminal
hydrolase isozyme L1 (UCHL1) and (b) promyelocytic leukaemia zinc finger protein (PLZF) during
passaging. Pre-c ltur : the igested testicula cells. P0: Primary passage. P1: Fir t passage. P3:
Third passage.
2.4. Sterilization of Nude Mice by Intratesticular Busulfan Injection
To eliminate endogenous germ cells for SSC transplantation, nude mice were sterilized using
intratesticular injection with either 75 or 150 µg busulfan. The efficiency of the intratesticular injection
of busulfan was va u t d by sacrificing two mice two weeks after injectio . Histological evaluation
demonstrated that both 75 and 150 µg of busulfan resulted in no spermatogenesis compared to the
multiple cell layers found in the non-treated control group (Figure 6a–c). The endogenous germ cell
devastation was confirmed by immunostaining with Sertoli cell marker SOX9 and germ cell marker
VASA (Figure 6d–i). We observed that 75 µg busulfan was sufficient to deplete the endogenous germ
cells, therefore, the recipient mice were prepared by intra-testicular injection with 75 µg of busulfan.
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Figure 6. Testis from nude mice sterilized by intratesticular busulfan injection. (a–c): Cross sectional
histological analysis of mouse testis by periodic acid–Schiff (PAS) staining. (a) nontreated control (b)
two weeks after intratestic lar busulfan injection with either 75 µg or (c) 150 µg. Scale bar: 50 µm.
(d–f): Cross sectional immunofluorescent analysis of mouse testis by Sertoli cell marker SRY-Box 9
(SOX9; red) and DNA visualization by DAPI staining (blue) (d) non-treated control (e) two weeks after
intratesticular busulfan injection with either 75 µg or (f) 150 µg. Scale bar: 100 µm. (g–i): Cross sectional
immunofluorescent analysis of mouse testis by germ cell marker VASA (red) and DNA visualization by
DAPI staining (blue) (g) non-treated control (h) two weeks after intratesticular busulfan injection with
either 75 µg or (i) 150 µg. Scale bar: 50 µm.
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2.5. The SSC-Like Cells Settle in the SSC Niche after Xenotransplantation
To verify SSC identity after propagation, xenotransplantation was performed. A total number of
13 million cells were collected after 2.5 months propagation with 3 passages and pre-labelled with green
fluorescent cell linker PKH67. Around one million labelled cells were transplanted into seminiferous
tubules of each testis via the efferent duct (Figure 7a). The colonies of PKH67 labelled cells in
seminiferous tubules of the recipient mice were identified after 3 and 6 weeks (Figure 7b,c). The number
of colonies was quantified as around 11 colonies (more than four cells in one cluster) with per million
transplanted cells after three and six weeks (Figure 7d). Whole-mount testicular immunostaining
showed that the SSC marker stage-specific embryonic antigen-4 (SSEA4) was expressed in PKH67
positive colonies (Figure 7e–h), indicating the successful migration of donor cells onto the basement
membrane of seminiferous tubules in recipients.
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Figure 7. Xenotransplantation of the human cells into busulfan treated nude mice. (a) Demonstration
of successful transplantation of human SSC-like cells into murine seminiferous tubules using trypan
blue. (b) PKH67 (a green fluorescent cell linker) pre-labelled cells forming colonies in recipient
testis merged with bright channel three weeks after transplantation. (c) PKH67 pre-labelled cells
forming colonies in recipient testis merged with DAPI staining six weeks after transplantation. (d)
Mean number with standard deviation of colonies formed numbers in recipient mouse testis. Three
weeks after transplantation (n = 1) and six weeks after transplantation (n = 3). (e–h): Whole mount
immunofluorescent analysis of mouse testis six weeks after transplantation by SSC marker, stage-specific
embryoni antigen-4 (SSEA4; red) and DNA visualization by DAPI staining (blue) (e) SSEA4; (f) PKH67;
(g) DAPI and (h) merged pictures from revious three channels. Scale bar: 50 µm.
3. Discussion
Establishment of a xeno-free culture condition to propagate human SSCs is a key step to advance
SSC transplantation to restore the spermatogenesis to the clinic level. Here we for the first time cultured
SSCs from infant boys using hPL and human serum albumin instead of xenogeneic factors and used
culture conditions compatible with clinical conditions. A total of 13 million cells from one sample
was harvested after three passages. Positive immunostainings and qPCR analysis of SSCLCs using
different SSC markers demonstrated the presence of SSCs. Furthermore, the functional properties of
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the propagated cells were validated by the positive recovery of SSCs which were transplanted into the
seminiferous tubules of immunodeficient mice after a grafting period of either three or six weeks.
This study demonstrates that human SSCs can be propagated under strict xeno-free conditions
to maintain functional and molecular characteristics of SSCs. Several other groups demonstrated
the possibility to cultivate human SSCs colonies from adult testis biopsies in co-culture with Sertoli
cells or on feeder-free conditions [20,21], or even after purification of SSC sorted via SSEA-4 or
GPR125 expression [22,23]. Recently, we reported the propagation of human SSC-like cells from
infant boys under xenogeneic culture conditions [24]. However, the media used in these studies
included animal-derived products such as BSA, FBS or other xenogeneic factors, which preclude
clinical utilization of the SSCs [25–28]. We investigated a clinically acceptable human substitution,
which is already used in a clinical setting, by replacing FBS with 2% hPL and replacing BSA with
human serum albumin. Therefore, the culture conditions described in the present study advances
human SSCs transplantation to the clinical level.
The starting material for our studies consisted with an average of around 8.5 mg testicular tissue
per sample in which histological examinations showed an average of 0.25 germ cells per seminiferous
tubule cross-section. This number of cells is lower than that in healthy boys at a similar age [29–31],
showing impairment of germ cell development in undescended testis [31,32]. The number of germ
cells per seminiferous tubule (age-matched) observed in prepubertal testicular tissue with a malignant
disease resembles or is slightly higher than those we observed in boys with bilateral cryptorchidism [33],
indicating that the methods developed in this study may have wider applications also in boys with
childhood cancer receiving potential gonadotoxic treatments.
SSCs were isolated by the differential plating method to enrich human SSCs under xenogeneic
conditions [22,23]. In our study, SSCLCs formed as grape-like cell clusters attached the fibroblast-like
cells after around 2 weeks. Individual big round cells were identifiable in the cell clusters compared
to the condensed SSC clusters using FBS media [34,35]. The different morphology may result from
a different exposure to hormones and growth factors in hPL and FBS. The morphological difference
of mesenchymal stem cells was also observed in hPL versus FBS media. While more elongated
spindle-shaped stem cells were found in hPL media, more flat cells were observed in FBS media [36].
We first validated the propagated SSCLCs evaluating putative SSC markers, UTF1, GFRα-1, and
UCHL1. UTF1 is a transcription repressor located in the nucleus regulating embryonic stem-cell
proliferation and differentiation [37] and plays a key role for the maintenance of SSC by the mediation
of the phosphatase and tensin homolog (PTEN) signaling pathway in mice [38]. In human testis, UTF1
is restricted to expression in spermatogonia [39,40]. In addition, Persio et al. [41] did not observe the
ki67 positive cells in UTF1 expressing spermatogonia in adult testis. We found UTF1 only localized in
the nucleus of SSCLCs and very few UTF1 positive cells showed proliferation marker, indicating the
most cell became quiesced in SSCLCs while only a few cells are proliferative active. GDNF secreted by
testicular somatic cells is required for SSC homeostasis [42]. GFRα-1, a human spermatogonial marker,
is a GDNF family receptor that mediates the GDNF-induced autophosphorylation and activation of
the RET receptor for SSC self-renewal [43,44]. GFRα-1 was found to be expressed in SSCLCs of the
present study, thereby further demonstrating the presence of SSCs in the clusters. Recently, testicular
cells were intensively characterized using single-cell RNA-Seq approaches, which identified the subset
populations of spermatogonia [45–47]. During the SSC proliferation and differentiation, primitive
spermatogonia have GFRα-1low UTF1high cell population and differentiate into GFRα-1high UTF1low
cell population based on pseudotime cell trajectory analysis of the sequencing data [48]. However,
Persio and co-workers investigated adult human testis mainly based on whole-mount immunostaining
approaches and suggested that the beginning of the spermatogenic lineage expresses a high level of
GFRα-1, then UTF1 subsequently becomes expressed and GFRα-1 expression decreases [41]. Despite
the controversial suggestions for the temporal expression during spermatogonial differentiation in
adult human testis, both subpopulations of spermatogonia are considered as part of the human SSC
pool. The SSCLCs contained UCHL1 positive cells which represent spermatogonia in adult testis [49].
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We and other studies [34,35,50] have determined the cell identity of propagated human SSCs
initially based on the expression of a group of putative SSC markers. However, recent studies
suggested that several putative SSC markers, such as PLZF, GFRα-1, UCHL1, and ITGA6 are also
expressed in testicular somatic cells [27,51]. To exclude debatable conclusion based on previous
markers, we performed immunostaining of an additional SSC marker UTF1, which was intensively
used to determine human SSCs in culture especially in the combination of SSEA4 [18].
To obtain additional evidence for the SSC nature of the propagated cells, we performed a
functional assay by transplantation of the propagated human cells to busulfan-treated immunodeficient
mice. Several xenogeneic SSC transplantations were successfully performed using busulfan-treated
immunodeficient male mice as recipients from different donor mammalian species, such as marmosets,
macaques, and humans [52–54]. The donor-derived germ cell colonies from all non-rodent mammals
were found in the basal lamina of mouse seminiferous tubules. However, the differentiation of
donor-derived SSCs was not observed in the recipient testis, probably due to the species-specific
differentiation factors in examined mammals [55]. Sadri-Ardekani and co-workers [34,35] were the
first to introduce xenotransplantation of propagated human cells into sterile nude mice. The authors
presented a single donor cell in mouse seminiferous tubules, which was not further characterized.
Mohaqiq et al. [56] observed spermatogenesis from transplanted human SSCs in mouse seminiferous
tubules after in vitro xenotransplantation which has different conditions compared to nude mice in vivo
xenotransplantation. In the present study, the donor-derived colonies with more than four cells were
identified in the recipient mouse testis three and six weeks after transplantation. Xenotransplantation
of freshly isolated human SSCs also formed human cell-derived colonies in seminiferous tubules of
recipient mice [28,57]. In general, the donor cell derived-colonies formation in immunocompromised
mice testis are considered to represent SSCs [58]. In addition, we investigated the cell identity by
whole-mount staining of recipient mouse testis using an SSC marker SSEA4 [59]. Almost all PHK67
pre-labelled transplanted cell shows the SSEA4 signals, indicating the transplanted human cells still
keep the SSC activity. A few single SSEA4 positive cells which were near to the PHK67 labelled
colony probably represent the remaining mouse endogenous germ cells after busulfan treatment. The
co-localization of mouse and human SSCs showed that a healthy mouse SSC niche also supported the
formation of human cells colonies. However, a definitive conclusion on whether human SSCs are the
colony-forming cells in the recipient mouse testis is lacking, and further functional assays need to be
developed to evaluate the self-renewal and differentiation capacity of human SSCs.
There are several limitations to our study. First, the SSCs could not be obtained purely as
they also contain some fibroblast-like cells. Moreover, the proliferation rate of SSCs could not be
calculated precisely since we did not quantify the population proportion of SSCs in culture by
fluorescence-activated flow cytometry. In addition, we performed the experiments from freshly
collected biopsy samples which may be different from freeze-thaw biopsies. Moreover, the composition
of hPL we used is not well defined and the key factors for the survival and proliferation of human SSC
in vitro need to be determined. Last but not least, the functionality of human cell-derived colonies in
recipient mice is awaiting further investigations.
4. Materials and Methods
4.1. Testicular Biopsies
Testicular biopsies samples were obtained from 2 patients (0.8 and 1.1 years old) undergoing
an operation for bilateral cryptorchidism and scheduled for cryopreservation. None of these boys
had previously received chemotherapy, radiotherapy or hormonal treatment. The present study was
approved by the ethical committee of the Capital Region of Copenhagen (H-2-2012-060, 11 June 2012).
In order to analyze the germ cells, testis tissue samples were fixed in Stieve’s solution overnight at room
temperature, embedded in paraffin, and sectioned at 2 µm. The histological sections were stained with
hematoxylin and eosin (HE), and immunohistochemical staining including, cluster of differentiation
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99 (CD99) (1:100, 12E7, Dako), Glostrup, Denmark, podoplanin (D2-40) (1:25, M3619, Dako) and
placental-like alkaline phosphatase (PLAP) (1:200, PL8-F6, Biogenex, Fremont, CA, USA). The number
of germ cells per tubular transverse section (G/T) and the number of Ad spermatogonia per tubular
transverse section were measured from HE stained sections as well as immunohistochemical staining
of CD99, D2-40, and PLAP [60]. For each patient, at least 100 cross-sectional tubules were examined.
4.2. Testicular Cell Isolation, Culture, and Cryopreservation
Fresh testicular biopsies weighing 7 and 10 mg were enzymatically digested by two steps,
firstly incubating in 450 U/mL collagenase type I (Worthington), 450 U/mL Hyaluronidase type II
(Sigma-Aldrich, Søborg, Denmark), 500 U/mL Trypsin TRL3 (Worthington) and 8 µg/mL DNase
for 15 min followed by incubating in 450 U/mL collagenase type I, 450 U/mL Hyaluronidase type
II and 8 µg/mL DNase for 30 min, to prepare a cell suspension. Testicular cells were collected
and cultured overnight in uncoated dishes in supplemented alpha-modified MEM media with
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), penicillin-streptomycin (100 µg/mL)
(Invitrogen), containing 10% hPL and 0.1% heparin (1000 IE/ml, Amgros, Denmark) at 35 ◦C and
5% CO2. After overnight incubation, floating cells were collected and cultured in uncoated dishes
with supplemented StemPro-34 (Gibco, Life Technologies, Nærum, Denmark). In addition, 0.5%
penicillin-streptomycin, recombinant human EGF (20 ng/mL, Sigma-Aldrich), recombinant human basic
FGF (10 ng/mL, Sigma-Aldrich) recombinant human GDNF (10 ng/mL, Sigma-Aldrich), recombinant
human LIF (10 ng/mL, EMD Millipore Corp), 2% hPL (Lot3, Rigshospitalet) and and 0.1% heparin
were added. The cells were cultured in Nunclon delta surface plates (Thermo Fisher Scientific, Nærum,
Denmark) at 35 ◦C in a humidified atmosphere with 5% CO2. Cells were passaged with Accutase
(Invitrogen) every 2–4 weeks to new dishes depending on the confluence of testicular cells in dish and
all cells were passaged three times.
4.3. Immunostaining
Testicular tissues or SSCLCs were embedded in alginate followed by 4% agarose, fixed in 4%
paraformaldehyde for around 16 h and 4 h, respectively, embedded in paraffin, and cut into 5 µm
sections. The sections were deparaffinized, subjected to antigen retrieval treatment using TEG buffer
(10 mM Tris, 0.5 mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA), pH
9), and blocked for 0.5 h at room temperature in 1% BSA in Tris-buffered saline (TBS) buffer (50
mM Tris, 150 mM NaCl, pH 7.6) before primary antibodies were applied. The following antibodies
were used: a mouse monoclonal anti-UTF1 antibody (1:50; Mab4337, Merck Millipore, Darmstadt,
Germany), a polyclonal rabbit anti- GFRα-1 antibody (1:50; ab84106, Abcam, Cambridge, UK), a mouse
monoclonal anti-UCHL1 (1:100, sc-271639, Santa Cruz, Heidelberg, Germany), a polyclonal rabbit
anti-Ki67 antibody (1:100; ab15580, Abcam), a polyclonal rabbit anti-SOX9 antibody (1:100; ab5535,
Merck Millipore), a polyclonal goat anti-human VASA antibody (1:100; AF2030, Novus biologicals,
Oxford, UK), and universal negative control serum (NC498H, Biocare Medical, Copenhagen, Denmark).
The slides were washed 3 times. For immune-fluorescence staining, the sections were stained with
an Alexa Fluor 594 donkey anti-goat IgG antibody (1:500 Jackson Immunoresearch, Skanderborg,
Denmark) or a FITC-conjugated donkey anti-mouse IgG antibody (1:500; Jackson Immunoresearch)
or Alexa Fluor 594 donkey anti-rabbit IgG antibody (1:500 Jackson Immunoresearch) for 1 h at
room temperature. The DNA was visualized using DAPI staining before mounting slides with
ProLong Gold Antifade Mountant (Life Technology). For immunohistochemical staining, sections
were merged in 1.5% H2O2 in TBS buffer to quench endogenous peroxidase before applying blocking
buffer. Signals were visualized on the section by incubation with the secondary antibodies, either
rabbit anti-mouse-HRP or goat anti-rabbit-HRP (1:100, Dako, Glostrup, Denmark) for 10 min at room
temperature, visualized by peroxidase reaction with 3,3′-diaminobenzidine tetrahydrochloride (Dako)
for 1–2 min, and counterstained with hematoxylin. Sections were analyzed with a Leica Microsystems.
Pictures were taken with a Leica digital camera.
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4.4. Gene Expression Analysis
Total RNA from cell clusters and dissolved single-cell suspensions were extracted with the
Absolutely RNA Nanoprep Kit (Agilent Technologies) according to the manufacturer’s instructions.
cDNA synthesis was performed with High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems) according to the manufacturer’s instructions. The gene expression was detected on the
LightCycler 480 Instrument II (Roche Diagnostics). The reaction mix consisted of 2 µL of template
cDNA, 5µL of Taqman universal PCR master mix (Applied Biosystems), 0.5µL of Taqman primer assays
specific for for glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Hs025978991_g1, Thermo Fisher
Scientific), for PLZF (Hs00957433_m1, Thermo Fisher Scientific), and for UCHL1 (Hs00985157_m1,
Thermo Fisher Scientific) and 2.5 µL of H2O to a final volume of 10 µL. A 96-well plate was used, and
each sample was run in duplicates. The PCR cycling conditions were set to one initiation cycle at 95 ◦C
for 10 min, followed by 45 cycles of 95 ◦C for 10 s 60 ◦C for 15 s, 70 ◦C for 10 s, and finally, one cycle at
95 ◦C for 1 min. The raw Ct value was reported from the Roche RCR software.
4.5. Xenotransplantation
The use of animals was approved by the Animal Experiments Inspectorate (case file
2015-15-0201-00505) under Danish legislation. Six nude mice homozygous for Foxn1 mutation
(Taconic, Borup, Denmark) were used. Mice were fed pellets and water ad libitum and kept under
controlled 12/12 h light/dark cycles at 20–22 ◦C. Mice were anaesthetized by use of zoletil (Virbac, Nice,
France), xylazin (Scanvet, Fredensborg, Denmark) and butorphanol (Zoetis, Parsippany, NJ, USA).
Postoperative analgesia was provided by the use of buprenorphine (ReckittBenckiser, England, UK)
and carprofen (Norbrook, England, UK). Mice were single-housed up until euthanasia, which was
done by cervical dislocation [61]. When the mice were 5 weeks old each testis was injected with the
doses of 75 or 150 µg busulfan (Sigma) dissolved in dimethyl sulfoxide (DMSO) and delivered in a total
volume of 20 µL through two different injection sites [62]. The sterilization efficiency was investigated
by PAS and immunostaining by sacrificing two mice after two weeks and SSC xenotransplantation was
performed according to the protocol [63]. Around one million of propagated cells in a volume of 15 µL
was injected through an efferent duct. The injection was visualized by the addition 0.04% Trypan Blue.
The propagated cells were pre-labelled by PHK67 (Sigma) according to manufacturer instructions [64].
4.6. Whole-Mount Immunofluorescence Staining of Seminiferous Tubules
The protocol of whole-mount immunofluorescence staining of seminiferous tubules was performed
with slight modification according to the literature [65]. Briefly, tunica was removed from recovered
mouse testis and the whole testis enzymatically digested with Collagenase IV (Gibco, Life Technologies)
and DNase I (Sigma) followed by fixation with 4% formaldehyde (Invitrogen). Seminiferous tubules
were stained with primary antibodies, mouse monoclonal IgG3 anti-SSEA4 (1:50, 60062, STEMCELL,
Cambridge, UK), secondary antibodies with Alexa Fluor 568 donkey anti-mouse IgG antibody (1:500,
Jackson immunoresearch). The DNA was visualized using DAPI staining before mounting slides
with ProLong Gold Antifade Mountant (Life Technology). Samples were analyzed with a Leica
Microsystems. A Leica digital camera was used for analysis and image capture.
5. Conclusions
We succeeded in the long-term culture of human SSCLCs starting from infant boys under xeno-free
conditions. In the biopsy specimens, one of the patients had quite a few germ cells, and even in
that case we managed to achieve many SSCLCs. The presence of specific SSC markers expressed in
SSCLCs in culture and the human cell-derived colonies formed in recipient mice by xenotransplantation
demonstrated the SSCLC activity. The results are encouraging for a continued research effort to develop
a clinically acceptable solution for maintaining fertility in young boys in need of preserving fertility.
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BSA Bovine Serum Albumin
EGF Epidermal growth factor
FBS Fetal Bovine Serum
FGF2 Basic fibroblast growth factor
GDNF Glial cell line-derived neurotrophic factor
GFRα1 GDNF family receptor alpha-1
hPL Human platelet lysate
MEM Minimum Essential Medium
ITGA6 Integrin alpha 6
ITT Immature testicular testis
LIF Leukaemia inhibitory factor
PLZF
PTEN
Promyelocytic leukaemia zinc finger protein
Phosphatase and tensin homolog
SSEA4 Stage-specific embryonic antigen-4
SSC Spermatogonial stem cell
SSCLC Spermatogonial stem cell-like cells
UCHL1 Ubiquitin carboxyl-terminal hydrolase isozyme L1
UTF1 Undifferentiated embryonic cell transcription factor 1
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